CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes President and CEO gave up 47,774 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 14,632 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,308 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,318 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,316 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 871 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 370 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 498 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 23,872 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,360 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 20,976 shares (to pay taxes)
Page 11 of 21 · 414 filings